Alterations in cerebral perfusion and substrate metabolism in type 2 diabetes: interactions with APOE-ε4
Diabetologia · 2025-06 · 68 (6) · 1315-1328
DOI: 10.1007/s00125-025-06405-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetologia, online erschienen am 11.04.2025. Verfasst von Martin Schain und 11 weiteren Autor:innen. Beteiligte Einrichtung: Antaros Medical, Mölndal, Sweden. martin.schain@antarosmedical.com. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Apolipoprotein E4, Cerebrovascular Circulation, Brain. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
AIMS/HYPOTHESIS: Epidemiological studies indicate that type 2 diabetes increases the risk for Alzheimer's disease. Alterations in cerebral metabolism have been proposed as a potential mechanism underlying this association. A better understanding of these metabolic changes may elucidate potential pathways linking type 2 diabetes to Alzheimer's disease. The aim of the current exploratory study was to investigate whether cerebral metabolism, including glucose and fatty acid uptake as well as cerebral blood flow, is altered in individuals with type 2 diabetes compared with both overweight individuals and lean control individuals. METHODS: This exploratory study included 38 participants (ten with type 2 diabetes, 13 overweight individuals and 15 lean control individuals). Brain metabolism was assessed using multiple imaging techniques: [18F]fluorodeoxyglucose and [18F]fluoro-6-thiaheptadecanoic acid positron emission tomography for glucose and fatty acid uptake; arterial spin-labelling MRI for cerebral perfusion; and 1H-magnetic resonance spectroscopy for specific metabolites. Neurodegeneration markers were evaluated from lumbar puncture samples. Group comparisons were assessed using one-way ANOVA and unpaired t tests, and correlations were assessed with linear regression. RESULTS: Individuals with type 2 diabetes exhibited lower cerebral glucose uptake compared with both lean and overweight groups (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Antaros Medical, Mölndal, Sweden. martin.schain@antarosmedical.com.
- Antaros Medical, Mölndal, Sweden.
- Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
- Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland.
- Late-Stage Development, Cardiovascular, Renal and Metabolism, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Zitieren
APA
Schain, M., Johansson, E., Laitinen, I., Frödén Löwenmark, A., Lubberink, M., Gummesson, A., Danfors, T., Nuutila, P., Esterline, R., Johansson, L., Oscarsson, J., & Heurling, K. (2025). Alterations in cerebral perfusion and substrate metabolism in type 2 diabetes: interactions with APOE-ε4. Diabetologia, 68(6), 1315-1328. https://doi.org/10.1007/s00125-025-06405-7
Vancouver
Schain M, Johansson E, Laitinen I, Frödén Löwenmark A, Lubberink M, Gummesson A, et al. Alterations in cerebral perfusion and substrate metabolism in type 2 diabetes: interactions with APOE-ε4. Diabetologia. 2025;68(6):1315-1328. doi:10.1007/s00125-025-06405-7
BibTeX
@article{Schain2025,
author = {Schain, Martin and Johansson, Edvin and Laitinen, Iina and Frödén Löwenmark, Anna and Lubberink, Mark and Gummesson, Anders and Danfors, Torsten and Nuutila, Pirjo and Esterline, Russell and Johansson, Lars and Oscarsson, Jan and Heurling, Kerstin},
title = {Alterations in cerebral perfusion and substrate metabolism in type 2 diabetes: interactions with APOE-ε4},
journal = {Diabetologia},
year = {2025},
volume = {68},
number = {6},
pages = {1315--1328},
doi = {10.1007/s00125-025-06405-7}
}
EUVIMED